Integrating the Psychedelic Renaissance and Broader Drug Policy Reform - Ethan Nadelmann at ICPR 24

In this captivating and thought-provoking lecture at the Interdisciplinary Conference on Psychedelic Research (ICPR), Ethan Nadelmann, the founder of the Drug Policy Alliance and the podcast Psychoactive, shares his personal journey and insights into the evolution of drug policy reform.
Learn more about ICPR: www.icpr-conference.com/
Background Ethan Nadelmann
Born in New York City and received his BA, JD, and PhD from Harvard, and a master’s degree in international relations from the London School of Economics. He then taught politics and public affairs at Princeton University from 1987 to 1994, where his speaking and writings on drug policy attracted international attention.
His talk at ICPR 2024
Nadelmann discusses the history and impact of the war on drugs in the United States, the rise of mass incarceration, and the global implications of drug policies. He delves into the psychedelic renaissance and its intersection with broader drug policy movements. Through a mix of autobiographical anecdotes and detailed analysis, Nadelmann provides a comprehensive overview of the past, present, and future of drug policy reform, advocating for science-based, compassionate, and human rights-centered approaches. This talk is a must-watch for anyone interested in understanding the complexities of drug policy and its profound societal impacts.
Timestamp Highlights
0:00 - Introduction, Early Years and Career Beginnings
2:35 - The War on Drugs in the 1980s and 1990s
8:32 - The Founding of the Drug Policy Alliance
16:48 - "The war on drugs is doing more harm than good."
23:25 - The US Paradox: From war on drugs to leader in decriminalization
31:30 - Ethan's message to the psychedelic community
39:30 - Audience Q&A Session
ICPR conference is organized by the non-profit OPEN Foundation: open-foundation.org/
Additional Resources
Drug Policy Alliance: drugpolicy.org/
Don't forget to like, comment, and subscribe for more insightful and interdisciplinary talks around psychedelic research and therapy.